A Bioequivalence Study of Capecitabine Tablets 500 mg in Adult Cancer Patients Under Fed Condition
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Colon Cancer|Breast Cancer
Interventions: DRUG: Capecitabine|DRUG: XELODA
Sponsor: Qilu Pharmaceutical Co., Ltd.